Oppenheimer & CO Inc Organon & Co. Transaction History

Oppenheimer & CO Inc

$6.42 Billion
Q3 2024

A detailed history of Oppenheimer & CO Inc transactions in Organon & Co. stock. As of the latest transaction made, Oppenheimer & CO Inc holds 18,899 shares of OGN stock, worth $279,138. This represents 0.01% of its overall portfolio holdings.

Number of Shares

18,899

Previous 27,424 31.09%

Holding current value

$279,138

Previous $567,000 36.33%

% of portfolio

0.01%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$18.65 - $23.03 $158,991 - $196,330	-8,525 Reduced 31.09%	18,899 $361,000
Q2 2024 Aug 07, 2024	SELL	$17.45 - $21.96 $255,886 - $322,021	-14,664 Reduced 34.84%	27,424 $567,000
Q1 2024 May 06, 2024	BUY	$13.78 - $18.8 $30,123 - $41,096	2,186 Added 5.48%	42,088 $791,000
Q4 2023 Feb 13, 2024	SELL	$10.95 - $17.32 $271,220 - $428,999	-24,769 Reduced 38.3%	39,902 $575,000
Q3 2023 Nov 07, 2023	SELL	$16.59 - $23.77 $35,137 - $50,344	-2,118 Reduced 3.17%	64,671 $1.12 Million
Q2 2023 Aug 02, 2023	SELL	$19.27 - $24.63 $985,756 - $1.26 Million	-51,155 Reduced 43.37%	66,789 $1.39 Million
Q1 2023 May 10, 2023	BUY	$21.42 - $32.08 $535,371 - $801,807	24,994 Added 26.89%	117,944 $2.77 Million
Q4 2022 Feb 07, 2023	SELL	$23.31 - $28.61 $205,873 - $252,683	-8,832 Reduced 8.68%	92,950 $2.6 Million
Q3 2022 Nov 14, 2022	SELL	$23.4 - $34.25 $309,886 - $453,572	-13,243 Reduced 11.51%	101,782 $2.38 Million
Q2 2022 Aug 08, 2022	SELL	$31.66 - $38.9 $90,547 - $111,254	-2,860 Reduced 2.43%	115,025 $3.88 Million
Q1 2022 May 12, 2022	BUY	$30.45 - $39.36 $1.1 Million - $1.43 Million	36,205 Added 44.33%	117,885 $4.12 Million
Q4 2021 Feb 02, 2022	SELL	$28.67 - $37.13 $100,660 - $130,363	-3,511 Reduced 4.12%	81,680 $2.49 Million
Q3 2021 Nov 12, 2021	BUY	$28.63 - $35.64 $250,168 - $311,422	8,738 Added 11.43%	85,191 $2.79 Million
Q2 2021 Aug 03, 2021	BUY	$28.45 - $38.0 $2.18 Million - $2.91 Million	76,453 New	76,453 $2.31 Million

Others Institutions Holding OGN

# of Institutions

794

Shares Held

193M

Call Options Held

1.71M

Put Options Held

865K

View Full List

About Organon & Co.

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.76B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

More about OGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer & CO Inc with notifications on news.

Account

Oppenheimer & CO Inc Organon & Co. Transaction History